Pulmonology (Lung Disease)
Research
Pulmonologists at Morgan Stanley Children's Hospital are leaders in research for furthering the understanding of respiratory disorders and evaluating new treatments.
The Division of Pulmonology is involved in basic research projects on:
- lung development;
- assessing numerous populations and how their disorders affect lung function and visa versa;
- evaluating transmission of allergic disorders;
- macrophage (a type of white blood that ingests foreign material) function interactions.
Pulmonary clinical research includes:
- evaluating health education for adolescents in New York City high schools (a five-year National Heart, Lung and Blood Institute grant)
- antibiotics in patients with cystic fibrosis
- how other disorders affect lung function
- developing a coalition approach to controlling asthma in Northern Manhattan
- evaluating the approach to the inpatient with asthma, and ensuring optimal care for those children
- optimizing care of high school students with asthma
Pediatric allergy and pulmonary specialists at Morgan Stanley Children's Hospital are collaborating in research protocols including projects on:
- primary instead of emergency care for asthma;
- developing asthma regulation by families and providers;
- enhancing family self-regulation of asthma in minorities.
Pulmonologists at Morgan Stanley Children's Hospital are participating in a nationwide observational research program - the Epidemiological Study of Cystic Fibrosis (ESCF) - designed to gather information about the care of patients with cystic fibrosis.
The Division of Pulmonology is also involved with benchmark laboratory research funded by the Cystic Fibrosis Foundation. The research is looking at the genetic modification of those immune system cells that protect against pulmonary infections related to cystic fibrosis. The goal is the development of a genetic vaccine.
Contact
- Pediatric Pulmonology
-
Directions
(212) 305-5122
